These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 1723049)
21. Involvement of the Y-1 receptor subtype in the regulation of luteinizing hormone secretion by neuropeptide Y in rats. Kalra SP; Fuentes M; Fournier A; Parker SL; Crowley WR Endocrinology; 1992 Jun; 130(6):3323-30. PubMed ID: 1317781 [TBL] [Abstract][Full Text] [Related]
22. Mitogenic effect of neuropeptide Y in rat vascular smooth muscle cells. Zukowska-Grojec Z; Pruszczyk P; Colton C; Yao J; Shen GH; Myers AK; Wahlestedt C Peptides; 1993; 14(2):263-8. PubMed ID: 8483806 [TBL] [Abstract][Full Text] [Related]
23. Structural requirements for neuropeptide Y in mast cell and G protein activation. Mousli M; Trifilieff A; Pelton JT; Gies JP; Landry Y Eur J Pharmacol; 1995 Mar; 289(1):125-33. PubMed ID: 7540143 [TBL] [Abstract][Full Text] [Related]
24. Y2 receptors for neuropeptide Y in the nucleus of the solitary tract mediate depressor responses. Barraco RA; Ergene E; Dunbar JC; Ganduri YL; Anderson GF Peptides; 1991; 12(4):691-8. PubMed ID: 1664944 [TBL] [Abstract][Full Text] [Related]
25. Reciprocal interactions between alpha 2-adrenoceptor agonist and neuropeptide Y binding sites in the nucleus tractus solitarius of the rat. A biochemic and autoradiographic analysis. Härfstrand A; Fuxe K; Agnati L; Fredholm B J Neural Transm; 1989; 75(2):83-99. PubMed ID: 2537374 [TBL] [Abstract][Full Text] [Related]
26. Characterization of Y3 receptor-mediated synaptic inhibition by chimeric neuropeptide Y-peptide YY peptides in the rat brainstem. Glaum SR; Miller RJ; Rhim H; Maclean D; Georgic LM; MacKenzie RG; Grundemar L Br J Pharmacol; 1997 Feb; 120(3):481-7. PubMed ID: 9031753 [TBL] [Abstract][Full Text] [Related]
27. Vasoconstrictor effects of various neuropeptide Y analogues on the rat tail artery in the presence of phenylephrine. Tschöpl M; Miller RC; Pelton J; Stoclet JC; Bucher B Br J Pharmacol; 1993 Nov; 110(3):1098-104. PubMed ID: 8298798 [TBL] [Abstract][Full Text] [Related]
28. Role of neuropeptide Y (NPY) in cardiovascular responses to stress. Zukowska-Grojec Z; Vaz AC Synapse; 1988; 2(3):293-8. PubMed ID: 3212674 [TBL] [Abstract][Full Text] [Related]
29. Localization of Y1 receptors for NPY and PYY on vascular smooth muscle cells in rat pancreas. Sheikh SP; Roach E; Fuhlendorff J; Williams JA Am J Physiol; 1991 Feb; 260(2 Pt 1):G250-7. PubMed ID: 1847590 [TBL] [Abstract][Full Text] [Related]
30. Increased vasopressor actions of intraventricular neuropeptide Y-(13-36) in spontaneously hypertensive versus normotensive Wistar-Kyoto rats. Possible relationship to increases in Y2 receptor binding in the nucleus tractus solitarius. Aguirre JA; Hedlund PB; Narváez JA; Bunnemann B; Ganten D; Fuxe K Brain Res; 1995 Jul; 684(2):159-64. PubMed ID: 7583217 [TBL] [Abstract][Full Text] [Related]
31. Neuropeptide Y receptor in vascular smooth muscle. Shigeri Y; Mihara S; Fujimoto M J Neurochem; 1991 Mar; 56(3):852-9. PubMed ID: 1847185 [TBL] [Abstract][Full Text] [Related]
32. Neuropeptide Y and peptide YY mediate nonadrenergic vasoconstriction and modulate sympathetic responses in rats. Zukowska-Grojec Z; Haass M; Bayorh MA Regul Pept; 1986 Sep; 15(2):99-110. PubMed ID: 3786837 [TBL] [Abstract][Full Text] [Related]
33. Pre- and postjunctional actions of neuropeptide Y and related peptides. Potter EK; Mitchell L; McCloskey MJ; Tseng A; Goodman AE; Shine J; McCloskey DI Regul Pept; 1989 May; 25(2):167-77. PubMed ID: 2756153 [TBL] [Abstract][Full Text] [Related]
34. The Y1 receptor subtype mediates the cardiovascular changes evoked by NPY administered into the posterior hypothalamic nucleus of conscious rat. Martin JR Brain Res; 2004 Mar; 1002(1-2):11-20. PubMed ID: 14988028 [TBL] [Abstract][Full Text] [Related]
35. Distinction of NPY receptors in vitro and in vivo. II. Differential effects of NPY and NPY-(18-36). Scott NA; Michel MC; Boublik JH; Rivier JE; Motomura S; Crum RL; Landon M; Brown MR Am J Physiol; 1990 Jul; 259(1 Pt 2):H174-80. PubMed ID: 2165363 [TBL] [Abstract][Full Text] [Related]
36. Neuropeptide Y/angiotensin II interactions in central cardiovascular regulation of the rat. Aguirre JA; Fuxe K; Hedlund P; Narváez JA; Cintra A; Rosén L; Agnati LF Brain Res; 1991 Dec; 566(1-2):61-9. PubMed ID: 1667611 [TBL] [Abstract][Full Text] [Related]
37. Effects of neuropeptide Y (NPY) at the sympathetic neuroeffector junction. Can pre- and postjunctional receptors be distinguished? Wahlestedt C; Håkanson R Med Biol; 1986; 64(2-3):85-8. PubMed ID: 3018392 [TBL] [Abstract][Full Text] [Related]
38. Galanin-neuropeptide Y (NPY) interactions in central cardiovascular control: involvement of the NPY Y receptor subtype. Díaz-Cabiale Z; Parrado C; Rivera A; de la Calle A; Agnati L; Fuxe K; Narváez JA Eur J Neurosci; 2006 Jul; 24(2):499-508. PubMed ID: 16903855 [TBL] [Abstract][Full Text] [Related]
39. Cardiovascular effects and modulation of noradrenergic neurotransmission following central and peripheral administration of neuropeptide Y. Westfall TC; Martin J; Chen XL; Ciarleglio A; Carpentier S; Henderson K; Knuepfer M; Beinfeld M; Naes L Synapse; 1988; 2(3):299-307. PubMed ID: 2850631 [TBL] [Abstract][Full Text] [Related]
40. Neuropeptide Y acts at an atypical receptor to evoke cardiovascular depression and to inhibit glutamate responsiveness in the brainstem. Grundemar L; Wahlestedt C; Reis DJ J Pharmacol Exp Ther; 1991 Aug; 258(2):633-8. PubMed ID: 1678015 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]